Copyright Reports & Markets. All rights reserved.

Global Endometrial Cancer Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Endometrial Cancer Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Endometrial Cancer Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Hysterectomy Techniques
    • 1.4.3 Radiation
    • 1.4.4 Hormone Therapy
    • 1.4.5 Chemotherapy
  • 1.5 Market by Application
    • 1.5.1 Global Endometrial Cancer Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Gynecology Centers
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Endometrial Cancer Market Perspective (2015-2026)
  • 2.2 Global Endometrial Cancer Growth Trends by Regions
    • 2.2.1 Endometrial Cancer Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Endometrial Cancer Historic Market Share by Regions (2015-2020)
    • 2.2.3 Endometrial Cancer Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Endometrial Cancer Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Endometrial Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Endometrial Cancer Players by Market Size
    • 3.1.1 Global Top Endometrial Cancer Players by Revenue (2015-2020)
    • 3.1.2 Global Endometrial Cancer Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Endometrial Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Endometrial Cancer Market Concentration Ratio
    • 3.2.1 Global Endometrial Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Revenue in 2019
  • 3.3 Endometrial Cancer Key Players Head office and Area Served
  • 3.4 Key Players Endometrial Cancer Product Solution and Service
  • 3.5 Date of Enter into Endometrial Cancer Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Endometrial Cancer Historic Market Size by Type (2015-2020)
  • 4.2 Global Endometrial Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Endometrial Cancer Market Size by Application (2015-2020)
  • 5.2 Global Endometrial Cancer Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Endometrial Cancer Market Size (2015-2020)
  • 6.2 Endometrial Cancer Key Players in North America (2019-2020)
  • 6.3 North America Endometrial Cancer Market Size by Type (2015-2020)
  • 6.4 North America Endometrial Cancer Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Endometrial Cancer Market Size (2015-2020)
  • 7.2 Endometrial Cancer Key Players in Europe (2019-2020)
  • 7.3 Europe Endometrial Cancer Market Size by Type (2015-2020)
  • 7.4 Europe Endometrial Cancer Market Size by Application (2015-2020)

8 China

  • 8.1 China Endometrial Cancer Market Size (2015-2020)
  • 8.2 Endometrial Cancer Key Players in China (2019-2020)
  • 8.3 China Endometrial Cancer Market Size by Type (2015-2020)
  • 8.4 China Endometrial Cancer Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Endometrial Cancer Market Size (2015-2020)
  • 9.2 Endometrial Cancer Key Players in Japan (2019-2020)
  • 9.3 Japan Endometrial Cancer Market Size by Type (2015-2020)
  • 9.4 Japan Endometrial Cancer Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Endometrial Cancer Market Size (2015-2020)
  • 10.2 Endometrial Cancer Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Endometrial Cancer Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Endometrial Cancer Market Size by Application (2015-2020)

11 India

  • 11.1 India Endometrial Cancer Market Size (2015-2020)
  • 11.2 Endometrial Cancer Key Players in India (2019-2020)
  • 11.3 India Endometrial Cancer Market Size by Type (2015-2020)
  • 11.4 India Endometrial Cancer Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Endometrial Cancer Market Size (2015-2020)
  • 12.2 Endometrial Cancer Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Endometrial Cancer Market Size by Type (2015-2020)
  • 12.4 Central & South America Endometrial Cancer Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Pfizer
    • 13.1.1 Pfizer Company Details
    • 13.1.2 Pfizer Business Overview
    • 13.1.3 Pfizer Endometrial Cancer Introduction
    • 13.1.4 Pfizer Revenue in Endometrial Cancer Business (2015-2020))
    • 13.1.5 Pfizer Recent Development
  • 13.2 Johnson & Johnson
    • 13.2.1 Johnson & Johnson Company Details
    • 13.2.2 Johnson & Johnson Business Overview
    • 13.2.3 Johnson & Johnson Endometrial Cancer Introduction
    • 13.2.4 Johnson & Johnson Revenue in Endometrial Cancer Business (2015-2020)
    • 13.2.5 Johnson & Johnson Recent Development
  • 13.3 Boston Scientific
    • 13.3.1 Boston Scientific Company Details
    • 13.3.2 Boston Scientific Business Overview
    • 13.3.3 Boston Scientific Endometrial Cancer Introduction
    • 13.3.4 Boston Scientific Revenue in Endometrial Cancer Business (2015-2020)
    • 13.3.5 Boston Scientific Recent Development
  • 13.4 GE
    • 13.4.1 GE Company Details
    • 13.4.2 GE Business Overview
    • 13.4.3 GE Endometrial Cancer Introduction
    • 13.4.4 GE Revenue in Endometrial Cancer Business (2015-2020)
    • 13.4.5 GE Recent Development
  • 13.5 Karl Storz
    • 13.5.1 Karl Storz Company Details
    • 13.5.2 Karl Storz Business Overview
    • 13.5.3 Karl Storz Endometrial Cancer Introduction
    • 13.5.4 Karl Storz Revenue in Endometrial Cancer Business (2015-2020)
    • 13.5.5 Karl Storz Recent Development
  • 13.6 Koninklijke Philips
    • 13.6.1 Koninklijke Philips Company Details
    • 13.6.2 Koninklijke Philips Business Overview
    • 13.6.3 Koninklijke Philips Endometrial Cancer Introduction
    • 13.6.4 Koninklijke Philips Revenue in Endometrial Cancer Business (2015-2020)
    • 13.6.5 Koninklijke Philips Recent Development
  • 13.7 Celgene
    • 13.7.1 Celgene Company Details
    • 13.7.2 Celgene Business Overview
    • 13.7.3 Celgene Endometrial Cancer Introduction
    • 13.7.4 Celgene Revenue in Endometrial Cancer Business (2015-2020)
    • 13.7.5 Celgene Recent Development
  • 13.8 Lupin
    • 13.8.1 Lupin Company Details
    • 13.8.2 Lupin Business Overview
    • 13.8.3 Lupin Endometrial Cancer Introduction
    • 13.8.4 Lupin Revenue in Endometrial Cancer Business (2015-2020)
    • 13.8.5 Lupin Recent Development
  • 13.9 LiNA Medical
    • 13.9.1 LiNA Medical Company Details
    • 13.9.2 LiNA Medical Business Overview
    • 13.9.3 LiNA Medical Endometrial Cancer Introduction
    • 13.9.4 LiNA Medical Revenue in Endometrial Cancer Business (2015-2020)
    • 13.9.5 LiNA Medical Recent Development
  • 13.10 Bayer AG
    • 13.10.1 Bayer AG Company Details
    • 13.10.2 Bayer AG Business Overview
    • 13.10.3 Bayer AG Endometrial Cancer Introduction
    • 13.10.4 Bayer AG Revenue in Endometrial Cancer Business (2015-2020)
    • 13.10.5 Bayer AG Recent Development
  • 13.11 Cooper Surgical
    • 10.11.1 Cooper Surgical Company Details
    • 10.11.2 Cooper Surgical Business Overview
    • 10.11.3 Cooper Surgical Endometrial Cancer Introduction
    • 10.11.4 Cooper Surgical Revenue in Endometrial Cancer Business (2015-2020)
    • 10.11.5 Cooper Surgical Recent Development
  • 13.12 Hologic
    • 10.12.1 Hologic Company Details
    • 10.12.2 Hologic Business Overview
    • 10.12.3 Hologic Endometrial Cancer Introduction
    • 10.12.4 Hologic Revenue in Endometrial Cancer Business (2015-2020)
    • 10.12.5 Hologic Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Endometrial Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endometrial Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Pfizer
    Johnson & Johnson
    Boston Scientific
    GE
    Karl Storz
    Koninklijke Philips
    Celgene
    Lupin
    LiNA Medical
    Bayer AG
    Cooper Surgical
    Hologic

    Market segment by Type, the product can be split into
    Hysterectomy Techniques
    Radiation
    Hormone Therapy
    Chemotherapy
    Market segment by Application, split into
    Hospitals
    Clinics
    Gynecology Centers
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now